Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0756
D

Failure to Address Pharmacy Recommendations for Medication Use

Emporium, Pennsylvania Survey Completed on 06-18-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that pharmacy recommendations were properly addressed by the attending physician for two residents reviewed for unnecessary medications. For one resident, the consultant pharmacist identified that daily supplements of Vitamin D and oyster shell calcium may be unnecessary and requested the physician to consider discontinuation, but there was no documented physician response. Additionally, the pharmacist requested an updated diagnosis to justify the combined use of Prozac and Zyprexa for treatment-resistant major depressive disorder. Although the physician indicated that orders were updated, the active orders continued to list previous diagnoses, and there was no evidence that the orders were revised to reflect the pharmacist's recommendation. For another resident, the consultant pharmacist noted that Risperidone was prescribed for dementia, which is not an approved diagnosis for this medication, and requested clarification. The physician later indicated the medication was for depression, but there was no documentation that the facility addressed or followed up on the physician's response to the pharmacist's recommendation. These findings were confirmed through clinical record review and staff interviews, indicating a failure to ensure that pharmacy recommendations were appropriately addressed and documented.

An unhandled error has occurred. Reload 🗙